AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02933996 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sham TEAS+GA group
Description: No electrical stimulation sensation is performed in the Sham TEAS group. In the Sham TEAS group, pseudo-stimulation is provided by deliberately connecting the electrodes to the incorrect output socket of the electroacupuncture device, and thus there is no flow of electric current. Patients could see the output light flashing but no current was transmitted throughout the procedure. Patients would be told that the stimulation frequency selected was not perceivable by human beings.
Study NCT01357564 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored Activity Program
Description: The interventionist, an occupational therapist, meets with the caregiver and introduces the intervention goals. The OT provides and reviews written educational materials about dementia, importance of taking care of self, communication strategies and other educational materials. Also provided and reviewed is The 36 Hour Day. The OT interviews the caregiver to obtain information about previous roles, habits, past and current daily routines, caregiver and Veteran preferences and interests. The OT also observes interactions, noting communication and management style. The OT will also meet with the Veteran, observe social capacity using the Peavy Comportment scale and administer the Dementia Rating Scale.
Study NCT01357564 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Attention Control
Description: Caregivers in this group received bi-weekly telephone contact by a trained healthcare professional. In each session, caregivers were provided information about dementia and strategies for disease management. Each telephone contact began with a brief overview the session purpose, followed by a description of key facts, and concluded with a question and answer period. The attention control group intervention was delivered by a member of the research team who is knowledgeable about dementia and has had prior experience working with family caregivers.
Study NCT02809677 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Non-Interventional
Description: This is a 52 week non-placebo controlled and non-randomized clinical research study to see whether treating Major Depressive Disorder (MDD) in caregivers of children with asthma will improve asthma outcomes in children. Caregivers may choose to receive an antidepressant medication that is considered standard medical care for MDD, or may opt out of antidepressant treatment. No treatment is withheld from participants and no placebos are used, thus there is no active intervention in this study.
Study NCT04978688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Relugolix
Description: Administered as an oral tablet once daily.
Study NCT04978688 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: E2/NETA
Description: Administered as an oral tablet once daily.
Study NCT01889277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-3995-Low
Study NCT01889277 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MT-3995-High
Study NCT01889277 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT03730324 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: ACTIVE_COMPARATOR
Intervention: Urine and plasma biomarkes.
Description: Study subjects will undergo urine and plasma biomarker testing prior to standard biopsy
Study NCT01745978 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Precut papillotomy
Study NCT02550379 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention
Description: Emotion Recognition Training
Study NCT02550379 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo Training
Study NCT00826397 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Acupuncture
Description: Each acupuncture session will last approximately 45 minutes and includes standardized body treatment with an emphasis on affected joints.
Study NCT01745978 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Precut papillotomy
Study NCT01346410 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Stereotactic Body Radiotherapy
Description: Suggested fractionation is 20-25 Gy / 1 fraction OR 30-36 Gy / 3 fractions (10-12 Gy per fraction) OR 40-45 Gy / 5 fractions (8-9 Gy per fraction)
Study NCT00979628 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: sliding scale regular insulin (SSRI)
Description: four-time daily in patients with T2DM admitted to general medicine and surgery wards.
Study NCT02037750 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: LINKS
Description: In the LINKS, foster/kin parents will participate in weekly group meetings led by well-trained and supervised paraprofessional facilitators (school behavioral aids and foster parents) where the curriculum is based on parent management training (PMT). In previous studies, attendance at such groups has been high, averaging about 75-80%. Missed sessions will be made up with an in-person visit to the foster/kin home during the week of the original session. In addition, youth in the intervention condition will receive individual skill building sessions from a Life Skills Coach to increase their competency at goal setting, refusal skills, and peer relations.
Study NCT03223935 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Corn nuts
Description: Roasted corn nut snack
Study NCT00979628 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Basal Bolus
Description: glargine once daily plus glulisine before meals (plus corrective doses of glulisine as needed)
Study NCT00979628 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Basal Plus
Description: glargine once daily plus corrective doses of glulisine before meals and bedtime as needed
Study NCT01044147 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VLM-S
Description: Online program for weight loss - standard
Study NCT01044147 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: VLM-M
Description: Online program for weight loss - modulated
Study NCT01044147 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: OGR
Description: Online program for weight loss - resources
Study NCT03787485 — intervention group
Intervention type: BEHAVIORAL
Intervention: LINKS
Description: The primary aim of LINKS is to create community-clinical linkages between three community health centers and their respective county health departments in southern Arizona. This study will also develop and evaluate a chronic disease and emotional well-being intervention that will connect clinic patients to community-centered, county-delivered, community health worker programs.
Study NCT01191255 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: ferric citrate, ca acetate, sevelamer carbonate, placebo
Description: All intervention doses will be based on serum phosphorus levels and/or drug label requirements
Study NCT01191255 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ferric citrate, ca acetate, sevelamer carbonate, placebo
Description: All intervention doses will be based on serum phosphorus levels and/or drug label requirements
Study NCT01191255 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ferric citrate, ca acetate, sevelamer carbonate, placebo
Description: All intervention doses will be based on serum phosphorus levels and/or drug label requirements
Study NCT01087879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Desogestrel-Ethinyl Estradiol contraceptive pill
Description: 150 microg Desogestrel and 20 microg Ethinyl Estradiol combination. One pill once a day for 9 weeks, continual administration.
Study NCT01087879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Etonogestrel-Ethinyl Estradiol vaginal ring
Description: Etonogestrel-Ethinyl Estradiol vaginal ring, which consists of 11,7 mg etonogestrel and 2,7 mg ethinyl estradiol. It delivers 0,120 mg etonogestrel and 0,015 mg ethinyl estradiol per day. Treatment continues continual for 9 weeks and the vaginal ring is changed every three weeks.
Study NCT01087879 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Norelgestromin-Ethinyl Estradiol contraceptive patch
Description: A combination transdermal contraceptive patch with 6 mg of norelgestromin and 600 microg of ethinyl estradiol. It delivers 203 microg of norelgestromin and 33,9 microg ethinyl estradiol per day. A continual use of patch for 9 weeks and the patch is changed every week.
Study NCT01333033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Oxaliplatin
Description: Given IV
Study NCT01333033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leucovorin Calcium
Description: Given IV
Study NCT01333033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fluorouracil
Description: Given IV
Study NCT01333033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Given IV
Study NCT01333033 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: Given IV
Study NCT01333033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Positron Emission Tomography
Description: Undergo PET/CT scan
Study NCT01333033 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Computed Tomography
Description: Undergo PET/CT scan
Study NCT01333033 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Undergo RT
Study NCT03445559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Clinical Order Check
Description: A Clinical Order Check is an evidence-based, systems-level method to affect significant behavior change. It addresses the intervention functions of education, enablement and incentivization which are effective methods to change behaviors driven by beliefs about capabilities, knowledge, social influences, beliefs about consequences, and environmental context and resources. All VA facilities currently use locally adapted clinical reminders. This strategy is technologically simple, straightforward, and is considered to be a best practice within the VA IT community. The reminder will be self-explanatory and non-intrusive to workflow.
Study NCT03445559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Academic Detailing
Description: Academic detailing is an individual and facility-level intervention consistently shown to improve provider behavior. This strategy addresses the intervention functions of persuasion, coercion, modeling, and education which are effective methods for affecting behaviors driven by beliefs about capabilities, knowledge, social influences, beliefs about consequences, and environmental context and resources. During the meeting, the detailer will follow a script explaining that the visit is part of an experimental program to provide physicians with up-to-date, unbiased information about imaging to stage prostate cancer.
Study NCT03445559 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Audit and Feedback
Description: Audit and feedback is an effective, individual-level intervention for changing healthcare provider behavior, resulting in small but potentially clinically important benefits. Audit and feedback addresses the intervention functions of education, persuasion and incentivization, all of which are important for addressing beliefs about capabilities and consequences, knowledge, and social influence.
Study NCT03572933 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ganaxolone
Description: active drug
Study NCT03572933 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: inactive
Study NCT03231618 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: 1. Low-fat and high-carbohydrate diet; 2. High-fat and low-carbohydrate diet; 3. High-protein and low-fat diet
Description: Every participate was provided with 3 types of diets in random order
Study NCT00131989 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: sorafenib tosylate
Description: Given orally
Study NCT00131989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT00131989 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT00306384 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Alogliptin
Description: Alogliptin tablets.
Study NCT03223935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Chickpeas
Description: Roasted chickpea snack
Study NCT03223935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Yellow peas
Description: Roasted yellow pea snack
Study NCT03223935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pinto beans
Description: Roasted pinto bean snack
Study NCT03223935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Soybeans
Description: Roasted soybean snack
Study NCT03223935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Almonds
Description: Roasted almond snack
Study NCT00984399 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Vagifem® (vaginal 17β-estradiol) questionnaire & menopause symptom checklist
Description: The goal is to have 30 patients on letrozole and 30 on anastrozole who are initiated on vaginal estrogen for symptoms of urogenital atrophy. All subjects will receive 10mcg vaginal 17-β estradiol tablets. Each subject will serve as her own control. We will monitor serum estradiol and follicle stimulating hormone (FSH) levels closely from 0-24 weeks. We will measure serum estradiol and FSH levels at baseline, and subsequently at weeks 2, 7, 12, 18 and 24 after commencing therapy with 10mcg vaginal 17-β estradiol.
Study NCT01198899 — intervention group
Intervention type: OTHER
Intervention: blood sampling
Description: Blood sampling will be used.
Study NCT03979235 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Motor function assessment
Description: perform motor function assessment by using scales, sEMG, and inertia sensors
Study NCT03876080 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Dry needling
Description: The use of a solid filiform needle to treat trigger points
Study NCT03876080 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham needling
Description: Simulated needling
Study NCT03059108 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Early Loading
Description: The procedure in this group will consist on placing implant-supported restorations over the implants placed 4 weeks earlier. The device (dental implant) is of the same type in both groups.
Study NCT03059108 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Loading
Description: The procedure in this group will consist on placing implant-supported restorations over the implants placed 8 weeks earlier. The device (dental implant) is of the same type in both groups.
Study NCT01318226 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATx08-001
Description: ATx08-001 will be administered as a 6mm white film coated tablet of 2.5 mg strength, to be taken orally at a dose of 2.5 mg or 7.5 mg, twice a day approximately every 12 hours over an 8 day period.
Study NCT01318226 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo will be administered as a 6mm white film coated tablet, twice a day approximately every 12 hours over an 8 day period. Placebo is identical in appearance to the ATx 08-001 tablet.
Study NCT00712023 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: warming device (a reusable, custom-made forced- air warming mattress)
Description: 2=forced-air warming mattress~1=circulating-water mattress
Study NCT00608582 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation, Repetitive
Description: 10 rTMS treatments (90% of motor threshold, 20 minutes, at 1 Hz) to specific right hemisphere area of brain cortex; 5 days per week for 2 weeks at the Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; or at the Neurology Department, Hospital of the University of Pennsylvania, Philadelphia, PA.
Study NCT00608582 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial Magnetic Stimulation, Repetitive
Description: 10 rTMS treatments (90% of motor threshold, 20 minutes, at 1 Hz) to specific right hemisphere area of brain cortex; 5 days per week for 2 weeks at the Berenson-Allen Center for Noninvasive Brain Stimulation, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA; or at the Neurology Department, Hospital of the University of Pennsylvania, Philadelphia, PA.
Study NCT03577717 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: computerized cognitive training
Description: participants will be trained 30 minutes/day, 3 days/week for 4 consecutive weeks.
Study NCT03577717 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: occupational therapy
Description: participants will receive craft activities of occupational therapy for 30 minutes/day, 3 days/week for 4 consecutive weeks.
Study NCT04050865 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexamethasone, 0.4mg
Description: Ophthalmic Insert
Study NCT04050865 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Placebo plug with no drug
Description: Ophthalmic Insert
Study NCT02675361 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Transition program
Description: Participants will be part of a transition program with eight key components: 1. A transition coordinator; 2. Education on congenital heart disease (CHD), treatments, health behavior, dealing with school, friends; 3. Telephone availability; 4. Information about the Grown-Up Congenital Heart Disease (GUCH) program: 5. Guidance of parents; 6. Meeting with peers: 7. A person-centered transition plan; and 8. Transfer to Grown-Up Congenital Heart Disease clinic. The intervention will be implemented by specialized nurses at the outpatient clinic of pediatric cardiology. Overall, 60 to 90 minutes per patient are spent over the 2.5 years.
Study NCT01288859 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: free curcumin
Description: free curcumin in bread, dosage 1g/100g, 200g/day per 1 day
Study NCT01288859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: encapsulated curcumin
Description: encapsulated curcumin-enriched bread, 1g/100g bread, 200g bread/day
Study NCT01288859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: encapsulated curcumin + PQG
Description: bread enriched with encapsulated curcumin plus piperine, quercetin and genistein, 1g/100g bread, 200g bread/day
Study NCT01288859 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: free cocoa polyphenol
Description: nut cream enriched with free cocoa polyphenols, 1,5 g/100g cream, 100g/day per 1 day
Study NCT01288859 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: encapsulated cocoa polyphenols
Description: nut cream enriched with encapsulated cocoa polyphenols, 1,5 g/100g cream, 100g/day per 1 day
Study NCT01288859 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: control nut cream
Description: nut cream, cocoa polyphenols 0g/100g cream, 100 g/day per 1 day
Study NCT04432597 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PRGN-2009 (Phase I)
Description: On the phase I portion of the protocol PRGN-2009 will be administered on Day (D)1, D15, D29 followed by booster vaccines every 4 weeks for up to a year. The dose level given as booster will be the same dose participants will be receiving for D1, D15 and D29.
Study NCT04432597 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PRGN-2009 (Phase II)
Description: On the phase II portion of the protocol PRGN-2009 will be administered on just Day (D)1 and D15.
Study NCT04432597 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: M7824
Description: Subjects enrolled to Arm 1B will receive M7824 (MSB0011359C) via intravenous (IV) infusion over 1 hour (-10 minutes / +20 minutes, that is, over 50 to 80 minutes) once every 2 weeks. M7824 will be administered as a flat dose of 1,200 mg independent of body weight. M7824 is administered as an intravenous infusion with a mandatory 0.2 micron in-line filter.
Study NCT04432597 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: MRI
Description: MRI (with gadolinium) of the neck, chest, skull, and/or sinonasal, if indicated, will be used when computed tomography (CT) scan is not an option to follow the disease.
Study NCT04432597 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Bone scan
Description: Bone scans and other imaging assessments may also be performed as clinically indicated.
Study NCT04432597 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: CT scan
Description: Imaging of the neck, chest, skull, and/or sinonasal, if indicated, will be performed every 8 weeks. In the event of a partial response (PR) or complete response (CR) tumor imaging assessments may be performed every 3 months (+/- 2 weeks) at the discretion of the investigator.
Study NCT04432597 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Brain CT
Description: Performed at baseline and may also be performed as clinically indicated by development of new specific symptoms or on the discretion of the Principal Investigator.
Study NCT04432597 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: EXPERIMENTAL
Intervention: Brain MRI
Description: Performed at baseline and may also be performed as clinically indicated by development of new specific symptoms or on the discretion of the Principal Investigator.